Instil Bio Inc.

NASDAQ: TIL · Real-Time Price · USD
28.02
-0.23 (-0.80%)
At close: Aug 15, 2025, 3:47 PM

Instil Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
3.61M 4.76M 5.99M 2.75M
Gross Profit
-3.61M -4.76M -5.99M -2.75M
Operating Income
-73.54M -90.54M -206.17M -155.56M
Interest Income
6.99M 8.87M 3.65M 80K
Pretax Income
-74.14M -156.09M -225.25M -156.75M
Net Income
-74.14M -156.09M -223.18M -156.79M
Selling & General & Admin
44.21M 42.8M 62.23M 48.31M
Research & Development
10M 42.99M 141.06M 107.25M
Other Expenses
19.33M n/a -3.11M n/a
Operating Expenses
73.54M 85.78M 200.18M 155.56M
Interest Expense
8.99M 5.21M 1.88M n/a
Selling & Marketing Expenses
n/a -4.76M n/a n/a
Cost & Expenses
73.54M 90.54M 206.17M 155.56M
Income Tax Expense
n/a n/a -2.07M 39K
Shares Outstanding (Basic)
6.51M 6.5M 6.48M 5.3M
Shares Outstanding (Diluted)
6.51M 6.5M 6.48M 5.3M
EPS (Basic)
-11.39 -24 -34.46 -29.6
EPS (Diluted)
-11.39 -24 -34.46 -29.6
EBITDA
-61.53M -146.12M -217.38M -154M
EBIT
-65.14M -150.88M -223.37M -156.75M
Depreciation & Amortization
3.61M 4.76M 5.99M 2.75M